- Home
- RDGT vs PPBT Comparison
RDGT vs PPBT Comparison
Compare RDGT & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDGT
- PPBT
- Stock Information
- Founded
- RDGT N/A
- PPBT 2010
- Country
- RDGT China
- PPBT Israel
- Employees
- RDGT N/A
- PPBT N/A
- Industry
- RDGT
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- RDGT
- PPBT Health Care
- Exchange
- RDGT NYSE
- PPBT Nasdaq
- Market Cap
- RDGT 6.4M
- PPBT 6.2M
- IPO Year
- RDGT N/A
- PPBT N/A
- Fundamental
- Price
- RDGT $1.30
- PPBT $2.33
- Analyst Decision
- RDGT
- PPBT Strong Buy
- Analyst Count
- RDGT 0
- PPBT 1
- Target Price
- RDGT N/A
- PPBT $33.00
- AVG Volume (30 Days)
- RDGT 61.5K
- PPBT 251.5K
- Earning Date
- RDGT 08-05-2025
- PPBT 08-15-2025
- Dividend Yield
- RDGT N/A
- PPBT N/A
- EPS Growth
- RDGT N/A
- PPBT N/A
- EPS
- RDGT N/A
- PPBT N/A
- Revenue
- RDGT $147,126,392.00
- PPBT N/A
- Revenue This Year
- RDGT N/A
- PPBT N/A
- Revenue Next Year
- RDGT N/A
- PPBT N/A
- P/E Ratio
- RDGT N/A
- PPBT N/A
- Revenue Growth
- RDGT N/A
- PPBT N/A
- 52 Week Low
- RDGT $0.72
- PPBT $2.00
- 52 Week High
- RDGT $4.50
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- RDGT N/A
- PPBT 40.95
- Support Level
- RDGT N/A
- PPBT $2.35
- Resistance Level
- RDGT N/A
- PPBT $2.90
- Average True Range (ATR)
- RDGT 0.00
- PPBT 0.17
- MACD
- RDGT 0.00
- PPBT 0.00
- Stochastic Oscillator
- RDGT 0.00
- PPBT 13.29
About RDGT RIDGETECH INC
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.